Recent Updates
Recently added Catalysts
PEN Positive Sentiment Score: 60/100

Penumbra, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for April 23, 2025 Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market...

Key Takeaway: Penumbra, Inc. announced its plans to host a conference call on April 23, 2025, to discuss the financial results for the first quarter of 2025. The call will take place after market close, with a press release providing detailed results released at that time. Interested parties can access the call via phone or webcast, which will also be available for two weeks following the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Penumbra will host a conference call to discuss positive financial results.
  • The company is recognized as a leader in thrombectomy technologies.
  • Innovations aim to improve patient outcomes and quality of life.

Full Press Release Details

ALAMEDA, Calif. , April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN ) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market close on Wednesday, April 23, 2025 at 4:30 PM Eastern Time . A press release with first quarter 2025 financial results will be issued after market close that day.
Webcast & Conference Call Information The conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com . The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram , LinkedIn and X .
Investor Relations Penumbra, Inc. [email protected]
SOURCE Penumbra, Inc.

21 %

Frequently Asked Questions

When will Penumbra announce its Q1 2025 financial results?

Penumbra will announce its Q1 2025 financial results on April 23, 2025.

How can I access the live conference call?

You can access the live call by dialing (888) 596-4144 with conference id 6572573.

Where can I find the webcast of the conference call?

The webcast is available in the 'Events and Presentations' section on Penumbra's website.

What does Penumbra focus on developing?

Penumbra specializes in innovative thrombectomy technologies for various medical conditions.

How long will the webcast remain available?

The webcast will be accessible for at least two weeks post-conference call.

Last updated: Apr 3, 2025